department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Shanghai Henlius Biotech Inc · pharmadog

PUBLIC COMPANY

Shanghai Henlius Biotech Inc

updated 1mo ago

community read0 votes

pipeline

8

marketed

1

phase 3

3

catalysts ytd

3

approvals ytd

0

recalls ytd

0

Pipeline(8)

pipeline depth8 products

3Phase 31Marketed3Unknown1pre_registration

Squamous Non-Small Cell Lung Cancer

Adenocarcinoma Of The Gastroesophageal Junction

Small-Cell Lung Cancer

Programmed cell death protein 1

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 1 initiation (1) · phase 2 initiation (2)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Shanghai Henlius Biotech Inc jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

Oncology4 NSCLC2 Ophthalmology1

mentioned in

0news items

entity-linker matched

HLX-3901

pre_registration

bevacizumab biosimilar

Cervical Cancer

Vascular endothelial growth factor A, long form

phase 1 initiation

Shanghai Henlius Biotech Inc — HLX-3901 (Phase I Trial Initiation)

phase 2 initiation

Shanghai Henlius Biotech Inc — HLX-35 (Phase II Trial Initiation)

phase 2 initiation

Shanghai Henlius Biotech Inc — HLX-43 (Phase II Trial Initiation)

Data sources

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagOncology9 co-mentions · 3 sources
tagApproval6 co-mentions · 3 sources
tagBreast Cancer5 co-mentions · 1 sources
drugBILPREVDA4 co-mentions · 2 sources
tagNSCLC3 co-mentions · 2 sources
tagPulmonology2 co-mentions · 2 sources
drugpertuzumab biosimilar2 co-mentions · 1 sources
drugdenosumab2 co-mentions · 2 sources